Thomas Moshiri, MD
Interventional Pain Medicine · Phoenix, AZNPI 1487628442
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.0%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Abbott at 49.9% of the total.
Across 255 payments — averaging $74.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$9K
- Globus Medical$3K
- Nevro Corp.$2K
- Nalu Medical, Inc.$1K
- Boston Scientific$1K
- Saluda Medical Americas, Inc.$571
- plus $987 from 5 others
What the payments were for
- Consulting fees$1,91310%
- Speaking & faculty fees$5,70830%
- Travel & lodging$1,3697%
- Food & beverage$9,87252%
- Other$1371%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 47 | $9,481 |
| Globus Medical(2 entities) | 28 | $2,693 |
| Nevro Corp. | 53 | $2,421 |
| Nalu Medical, Inc. | 61 | $1,441 |
| Boston Scientific | 32 | $1,404 |
| Saluda Medical Americas, Inc. | 11 | $571 |
| Vertos Medical, Inc. | 10 | $409 |
| Stryker | 6 | $268 |
| Merit Medical Systems Inc | 1 | $137 |
| Medtronic | 3 | $109 |
| Foundation Fusion Solutions, LLC | 3 | $63 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$8,272
- Senza$2,817
- Nalu Neurostimulation System$401
- Evoke$384
- Omnia$308
- mild Device Kit$290
- GENERAL PAIN MANAGEMENT$274
- Superion Indirect Decompression System$159
- Senza Spinal Cord Stimulation System$139
- SPINEJACK$138
- CORRIDOR$135
- SUPERION$122
How this compares
$18,998 in reported general payments places this provider in the 75th percentile of 64 interventional pain medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 55 | $375 |
| Cefadroxil | 57 | $315 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 46 | $274 |
| Cyclobenzaprine Hcl | 38 | $149 |
| Tramadol Hcl | 21 | $38 |
| Oxycodone Hcl | 14 | $30 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Phoenix
- Steven SiwekPhoenix$57K
- Ramoun JonesPhoenix$51K
- Lisa StearnsPhoenix$48K
- Jerome GrovePhoenix$21K
- Abram BurgherPhoenix$15K
- Adam SiwekPhoenix$14K
- Todd TurleyPhoenix$13K
- Jarrett LeathemPhoenix$11K
- Ankit PatelPhoenix$8K
- Chhavi ManchandaPhoenix$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.